Skip to main content

Advertisement

SpringerLink
Log in

A systematic review on the effect of bevacizumab in exudative age-related macular degeneration

  • Letter to the Editor
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bashshur ZF, Schakal A, Hamam RN, El Haibi CP, Jaafar RF, Noureddin B (2007) Intravitreal bevacizumab vs verteporfin photodynamic therapy for neovascular age-related macular degeneration. Arch Ophthalmol 125:1357–1361

    Article  CAS  PubMed  Google Scholar 

  2. Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T (2009) Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 116:57–69

    Article  PubMed  Google Scholar 

  3. Lazic R, Gabric N (2007) Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 245:68–73

    Article  CAS  PubMed  Google Scholar 

  4. Hahn R, Sacu S, Michels S, Varga A, Weigert G, Geitzenauer W, Vecsei-Marlovits P, Schmidt-Erfurth U (2007) Intravitreal bevacizumab versus verteporfin and intravitreal triamcinolone acetonide in patients with neovascular age-related macular degenereation. Ophthalmologe 104:588–593

    Article  CAS  PubMed  Google Scholar 

  5. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431

    Article  CAS  PubMed  Google Scholar 

  6. Wu L, Martínez-Castellanos MA, Quiroz-Mercado H, Arevalo JF, Berrocal MH, Farah ME, Maia M, Roca JA, Rodriguez FJ, Pan American Collaborative Retina Group (PACORES) (2008) Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol 246:81–87

    Article  CAS  PubMed  Google Scholar 

  7. Fung AE, Rosenfeld PJ, Reichel E (2006) The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 90:1344–1349

    Article  CAS  PubMed  Google Scholar 

  8. IVAN Study. www.controlled-trials.com. ISRCTN92166560. Accessed July 30, 2009

  9. CATT Study. www.clinicaltrials.gov. NCT00593450. Accessed July 30, 2009

  10. EQUAL Study. http://apps.who.int/trialsearch/. NTR1331. Accessed July 30, 2009

  11. VIBERA Study. www.clinicaltrials.gov. NCT00559715. Accessed July 30, 2009

Download references

Author information

Authors and Affiliations

  1. German Cochrane Centre, University Medical Centre Freiburg, Freiburg, Germany

    Christine Schmucker & Gerd Antes

  2. Health Technology Assessment Centre, University Bremen, Bremen, Germany

    Monika Lelgemann

Authors
  1. Christine Schmucker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerd Antes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Monika Lelgemann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christine Schmucker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmucker, C., Antes, G. & Lelgemann, M. A systematic review on the effect of bevacizumab in exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 248, 451–452 (2010). https://doi.org/10.1007/s00417-009-1249-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-009-1249-5

Keywords

Search

Navigation